Healthcare in Uruguay: System, Insurance, Ratings, Problems, and Costs

Uruguay has a comprehensive healthcare system that integrates the public and private sectors under the National Integrated Health System (Sistema Nacional Integrado de Salud, SNIS). Established in 2007, this system has since provided universal coverage of health services for the entire population.

1. How does the system work?

Funding is organised through the National Health Fund (Fondo Nacional de Salud, FONASA), which receives mandatory deductions from employees' pay, employer contributions and public funds. The state, through the Ministry of Public Health (MSP), acts as regulator: it sets care rules, monitors quality, establishes maximum waiting times for health services and applies sanctions for breaches. The state also owns the largest provider, ASSE (the State Health Services Administration), which operates a network of public hospitals and outpatient clinics throughout the country.

2. Public or private healthcare?

The private sector is represented chiefly by so-called sociedades médicas, or mutualistas: non-state, non-profit medical organisations that own hospitals and clinics. People participating in FONASA can choose either the public provider, ASSE, or one of the private mutualistas.

In practice, most people prefer private mutual plans. Uruguay has more than 40 private mutualistas, and they enrol most insured people. Mutualistas operate on a membership basis: for a monthly contribution, they provide a broad package of services without deductibles or limits on the amount or number of visits.

Private clinics and hospitals therefore play a key role and provide the main share of health services, while public hospitals complement the system, particularly for people without coverage and in remote regions.

Insurance companies as separate financial intermediaries occupy a less important niche in Uruguay. Apart from mutualistas, only a small share of the population buys supplementary private policies for premium services and clinics. Such private insurers—for example BlueCross & BlueShield Uruguay, Medicina Personalizada MP and Summum—usually offer higher-level service or international cover at an additional cost, but are not part of SNIS. Overall, the state coordinates both sectors: the MSP licenses all providers, oversees standards and, through JUNASA (the National Health Council), manages distribution of FONASA funds among providers.

3. Health insurance and choosing a healthcare provider

Uruguay's healthcare model effectively combines elements of social insurance and a ‘single purchaser’ system. All formally employed residents and employers contribute to FONASA, creating a fund that finances both public and private institutions. In return, every insured person can choose care in ASSE or in one of the private mutualistas.

Initial enrolment usually takes place when a person starts employment or becomes entitled to cover, but there is also a mechanism for periodically changing institutions: once a year, you may change healthcare provider. You must apply in person to the chosen new mutualista during the month corresponding to the last digit of your identity-card number.

This ‘open enrolment’ is spread across the year—for example, if an identity-card number ends in 7, the change is made in July—which prevents system overload.

Besides the annual open campaign, exceptional cases for changing provider at any time have existed since 2023: if the current provider seriously breaches established care waiting times or another major access or quality problem arises, a patient may complain and obtain MSP permission to move to another organisation outside the schedule.

This measure followed complaints about prolonged queues: the new regulation (Decree No. 114/023) expressly permits an early switch to another mutualista when regulatory waiting times for specialists or examinations are not met. From 2023 to May 2025, 253 patients asked to change institution for these reasons; the state granted 205 requests (214 of the 253 applicants were ASSE users seeking to move to private mutual societies). This mechanism encourages competition and provider discipline.

To let people make an informed choice of provider, the Ministry of Public Health launched a dedicated comparison service. The A Tu Servicio portal ( atuservicio.uy ) publishes annual data on every medical organisation in SNIS. Users can compare key mutualista indicators: average waits for appointments across specialties, availability of specialists, bed capacity, satisfaction measures and more.

That transparency is a distinctive feature of the system: the data creates a de facto attractiveness ranking of hospitals and clinics. Premium commercial insurers, as distinct from mutualistas, are not integrated into this comparison system and do not publish their prices.

Nevertheless, the overwhelming majority choose between roughly forty mutualistas and public ASSE, and competition for patients prompts institutions to improve service.

4. Modern technology and telemedicine

Uruguay actively invests in medical technology and health digitalisation: sector spending is about 9% of national GDP and is projected to reach around 10% by 2027. In 2012, the government launched Salud.uy to create a national digital-health ecosystem. By 2017, rules required every health provider to implement electronic medical records (Historia Clínica Electrónica Nacional, HCEN): by 2020 at least 90% of patient interactions had to be recorded electronically. All major hospitals and clinics now maintain digital records, and patient data is available, subject to confidentiality, to doctors in different institutions.

A national e-prescription system was introduced on this infrastructure in 2019: doctors can issue prescriptions online, and patients obtain medicines at the pharmacy through a digital record rather than a paper form.

Many pharmacies offer medicine delivery, a service especially sought during the COVID-19 pandemic. Since 2019, the Unified National Diagnostic Imaging Network has also operated: results of examinations such as X-rays, MRI and CT scans are uploaded to a shared system that specialists anywhere in the country can quickly review. This removed the need to transport films or discs and accelerated diagnosis, especially in urgent cases.

Telemedicine has become one of the most promising areas. Uruguay adopted its first telehealth law, Ley 19.869, in March 2020, establishing the legal framework for remote medical services. Remote consultations have developed actively since then. The public sector has advanced particularly far: by the end of 2024, ASSE had implemented a National Telemedicine Plan, equipping 105 centres nationwide for video consultations, training more than 1,000 staff and deploying remote consultations in 33 specialties. Telemedicine already connects patients in rural and remote regions with specialists in the capital, reducing long trips and waiting times.

Remote consultations are especially sought in psychiatry, dermatology, endocrinology and other fields with too few local doctors. Their development promotes more equal access to quality care by reducing geographical disparities in specialist distribution.

Uruguay also takes pride in its strong medical workforce: it has 4.6 doctors per 1,000 residents, the second-highest figure in Latin America and the eleventh-highest worldwide.

On this measure, Uruguay outperforms neighbouring countries: by comparison, Brazil and Argentina have around 2–4 doctors per 1,000 residents, and Chile about 2–3.

Strong staffing is partly explained by good medical education and attractive working conditions. Yet the country's small scale has a downside: specialists find it harder to gain extensive experience with rare or complex cases in one small population. Uruguay therefore encourages doctors to undertake placements abroad and uses tele-second opinions with overseas clinics so people with rare diseases can consult leading experts.

5. Problems and patient complaints

Despite its successes, Uruguayans often express dissatisfaction with particular aspects of healthcare. The most frequent complaint is queues and delays in receiving care. Survey data identifies waiting time as the system users' main grievance. In some cases, patients wait several months for appointments with in-demand specialists—such as neurologists, endocrinologists and dermatologists—especially at mutualistas with large memberships. In private discussions, patients mention waits of months in psychiatry, neurology and some surgical specialties.

This is explained by overburdened doctors: an excessive number of patients in popular mutualistas leaves too few available appointment slots. There are also complaints of ‘low service quality’: insufficient attention from staff, outdated conditions in some clinics, a cold attitude, and so on. Overcrowded emergency departments, particularly at public hospitals, and long registration queues also frequently appear in citizens' reviews.

Uruguay has set maximum permissible waiting times for medical care by regulation. Under SNIS rules, in force since 2007, a consultation with a general practitioner, paediatrician or gynaecologist must be provided within 24 hours of the request, an appointment with a general surgeon within 48 hours, and a specialist consultation—for example with a cardiologist or neurologist—within 30 days.

Elective, non-urgent surgery must take place no later than 180 days after it is prescribed. These standards are quite progressive, but are not always met, particularly in the public sector and overburdened mutualistas. The Ministry of Public Health acknowledges non-compliance and regularly takes action: providers that breach waiting-time rules may be fined. Between 2019 and 2024, the MSP fined at least ten medical institutions for exceeding limits; its maximum fine, 200 UR or around 365,000 pesos, was imposed on ASSE in 2024.

At the same time, the regulator gives proactive patients a tool to exert influence: as noted above, more than two hundred people have already exercised their right to switch institutions early because of excessive waits.

6. Medicines: prescription, availability and prices

Uruguay has a strict medicine-dispensing system. There are three types of prescription, distinguished by colour and purpose: a white prescription for most prescription medicines; a green or blue prescription for psychotropics such as antidepressants and benzodiazepines; and a yellow or orange prescription for narcotic or opioid analgesics and other particularly controlled substances. Every registered medicine has a dispensing status set by the Ministry of Public Health: strictly prescription-only; prescription with repeat dispensing; on medical recommendation (médico recomendada—a category of medicines that may formally be sold without a prescription but for which medical advice is desirable); or fully over the counter.

Antibiotics, hormonal and cardiovascular medicines, among others, are therefore sold only on an appropriate prescription, while some over-the-counter medicines, such as analgesics and certain cold remedies, are freely available. The Ministry issues doctors special green and yellow forms for psychotropic and narcotic medicines in limited quantities, and pharmacies account strictly for every medicine dispensed on them; the system is intended to prevent misuse of controlled medicines.

Uruguay was one of the first countries in the region to move to electronic prescriptions, simplifying the purchase of medicines.

In terms of medicine availability, Uruguay is well placed. Around 7,000–8,000 medicines are registered on the market and, even when a particular brand is temporarily absent, equivalents with the same active ingredient are usually available, supported by both local pharmaceutical production and parallel imports from different countries.

Government policy includes central procurement of a number of essential medicines through tenders, which ensures their availability in public hospitals. However, central tenders can lead to shortages until the next delivery if the winning company experiences supply disruptions.

Industry representatives note that Uruguay has very high per-capita medicine use while the average price is relatively low. According to the head of the Pharmaceutical Laboratories Association, the average price per pack is about 40–45 Uruguayan pesos, around $1—significantly lower than in many other countries and one of the lowest in Latin America.

This naturally concerns common generics and mass-market medicines. The newest imported medicines can be expensive—innovative diabetes or oncology drugs, for example, can cost hundreds of dollars—but the state helps here.

Uruguay differs favourably from its neighbours by financing expensive medicines for citizens with serious diseases. Since the 2007 reform, the special National Resources Fund (FNR) has paid for high-cost treatment programmes: costly surgery, prostheses and high-cost medicines. As of 2019, the Uruguayan system provided 56 expensive medicines free of charge for 39 different diseases, with no patient co-payment.

This is a unique situation in Latin America: in many neighbouring countries such medicines are either unavailable or require a long bureaucratic struggle, litigation or substantial personal costs. In Uruguay, the principle is that if high-cost treatment is included in a programme after an assessment of its effectiveness, the patient is guaranteed to receive it without financial burden. For example, modern targeted oncology medicines, biological treatment for rare diseases and certain newer diabetes medicines, including injectable GLP-1 analogues, are issued by the state after approval by an FNR medical committee. Centralised procurement, with the state acting as a single large purchaser and sometimes through the WHO/PAHO Strategic Fund, reduces prices and ensures sustainable funding.

As a result, even patients who need medicines costing millions are not left without treatment: Uruguay fulfils this social function better than any other country in the region.

7. Cost of health insurance

One appealing feature of Uruguayan healthcare is the comparatively low cost of insurance cover. Citizens in FONASA through an employer barely feel direct costs: their ‘premium’ is deducted from salary, roughly 3–8% depending on income and number of dependants, while the state pays the rest. Even people not formally employed, such as pensioners without a sufficient employment record, self-employed people and expats, can join a mutualista for a fee. The monthly cuota for a full healthcare plan is around 3,500–4,000 Uruguayan pesos per adult.

That is about US$90–100 per month, or around $1,100–1,200 a year. Children cost less, about 2,200 pesos a month, around $55. A family of three can therefore expect a full package of health services for about $200 a month, considerably less than comparable private insurance in North America or Europe.

According to estimates for expats, the typical price range for private health plans in Uruguay is $80–150 a month per person, depending on the chosen mutualista and service package.

More expensive plans, closer to $150, usually offer extended service: higher-comfort rooms, faster specialist access, dental care and glasses, possibly international cover. But basic plans are quite good and sit at the lower end, around $80–100. In Maldonado, for example, a standard plan at the local La Asistencial clinic costs about $57 a month, while the top-tier VIP plan costs about $150.

Annual membership thus averages around 40,000–50,000 UYU, or about USD 1,000–1,300. The state subsidises low-income people: formally unemployed people and those with very low incomes can use the public ASSE system free of charge, while children and dependants of FONASA contributors are covered without extra payment. Taken together, these healthcare costs are considered affordable for the middle class given the quality of services. Care obtained through insurance also does not involve large co-payments: there are no equivalents of deductibles or a required percentage of the bill; the patient pays only small fixed tickets for appointments—about 180 pesos for a general practitioner and 448 pesos for a specialist—and for prescriptions, as mentioned above.

All major high-cost services, including operations, inpatient treatment and childbirth, are fully covered. This predictability of costs is an important feature of the Uruguayan system.

8. Comparison with other countries in the region

In the Latin American context, Uruguay's healthcare system is considered one of the most accessible and highest-quality healthcare systems in the region.

International studies place Uruguay among the region's leaders: in the global Healthcare Access and Quality Index (HAQ, a Lancet study), Uruguay ranked 68th worldwide, ahead of neighbours Argentina at 83rd and Brazil at 96th, and behind only Chile, 49th, in South America.

This confirms that across indicators such as population coverage, health outcomes and effectiveness in treating preventable diseases, Uruguay sits in the upper part of the ranking and outperforms the region's larger countries.

Argentina also has a broad system—free public hospitals, obras sociales insurance funds and private cover—and formally anyone can receive care. Yet Argentina's system is highly fragmented and uneven: service quality is high in the capital and wealthy provinces but much worse in remote regions. Queues and public-hospital overload are often more serious than in Uruguay and, although Argentina spends a comparable GDP share on healthcare, it uses that spending less efficiently. Uruguay benefits from a more coherent organisation: a single FONASA fund and SNIS provide a standard package nationwide, while different Argentine providers offer unequal access.

Chile is recognised as one of Latin America's healthcare-quality leaders, ranking above Uruguay in some measures, but it has a more stratified model. About 80% of Chileans use the public insurer FONASA, with limitations and queues similar to those in Uruguay, and about 20% use expensive private ISAPRE insurance that provides high service levels.

Uruguay's system is more universal: virtually everyone, about 99%, is covered by a single mechanism, without such a sharp difference in care between social groups. Uruguay has also historically focused on prevention and primary care: vaccination, maternal health and infection-control programmes are among the region's best. On key outcomes such as life expectancy and child mortality, Uruguay is roughly at Argentina's level and behind Chile, with its very low infant mortality and long life expectancy, but significantly ahead of major neighbours such as Brazil.

Brazil, a huge country, has the universal public SUS system, but resource and management problems make actual quality vary considerably. By comparison, Uruguay appears more manageable and equitable: its small population, about 3.5 million, is easier to cover. In Brazil, though the right to free care is guaranteed, waits for operations can last years in practice and many who can afford it buy private plans. In Uruguay, the share of private insurance beyond basic cover is minimal, indicating public trust in the system. Brazil also lags on a number of health indicators and global rankings place its system far below Uruguay's.

Overall, Uruguay, Chile and Cuba are often cited as examples of Latin America's most successful healthcare systems.

Uruguay has managed, as a small country, to achieve almost complete universal coverage, decent service quality and many innovations, including e-health and telemedicine. The main future challenges are reducing waiting times for specialists, further improving spending efficiency and responding to new epidemiological threats. But on access and quality measures, Uruguay already holds a leading position in the region and provides its citizens with a high standard of healthcare.

You can arrange permanent residency in Uruguay yourself—our guide gives clear step-by-step instructions.

If you do not want to spend your time studying the application process and carrying it out, you can always use Anna Bamburova's services to complete it comfortably and in the shortest possible time, receive a full action plan for permanent residency and the cédula ID card, and benefit from extensive experience in settling into Uruguay.

Have questions? Contact Anna at Follow Uruguay news in our